Rocket Pharmaceuticals Inc (RCKT)

Precedente Chiudi:

$23.40

Aprire:

$23.46

Volume 24 ore:

552.57K

Capitalizzazione di mercato:

$2.05B

Reddito:

-

Utile/perdita netta:

$-245.60M

Rapporto P/E:

-6.8338

EPS:

-3.31

Flusso di cassa netto:

$-211.39M

1 W Prestazione:

-0.44%

1M Prestazione:

-4.48%

6M Prestazione:

+3.05%

1 anno Prestazione:

+4.92%

Intervallo 1D:

$22.45

$23.56

Portata 52W:

$14.89

$32.52

Rocket Pharmaceuticals Inc Stock (RCKT) Company Profile

Nome

Rocket Pharmaceuticals Inc

Settore

Healthcare (1209)

Industria

Biotechnology (699)

Telefono

646-440-9100

Indirizzo

430 East 29th Street, Suite 1040, New York, NY

Dipendente

33

Cinguettio

@rocketpharma

Prossima data di guadagno

2024-06-13

Ultimi documenti SEC

RCKT's Discussions on Twitter

Rocket Pharmaceuticals Inc Stock (RCKT) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2023-10-24	Iniziato	Cantor Fitzgerald	Overweight
2023-02-01	Iniziato	Morgan Stanley	Overweight
2022-11-08	Iniziato	Canaccord Genuity	Buy
2022-11-01	Iniziato	BTIG Research	Buy
2022-07-08	Iniziato	Raymond James	Outperform
2021-10-20	Ripresa	Cowen	Outperform
2021-03-02	Iniziato	Stifel	Buy
2021-02-18	Iniziato	Needham	Buy
2020-12-16	Iniziato	UBS	Buy
2020-12-08	Downgrade	Oppenheimer	Outperform → Perform
2020-07-02	Iniziato	JP Morgan	Overweight
2020-06-25	Ripresa	BofA/Merrill	Buy
2020-06-01	Ripresa	Oppenheimer	Outperform
2019-11-06	Iniziato	Chardan Capital Markets	Buy
2019-09-26	Iniziato	Piper Jaffray	Overweight
2019-04-23	Iniziato	Robert W. Baird	Outperform
2019-03-15	Iniziato	BofA/Merrill	Buy
2019-02-05	Iniziato	Oppenheimer	Outperform
2018-09-13	Iniziato	Ladenburg Thalmann	Buy
2018-07-10	Iniziato	William Blair	Outperform

Mostra tutto

Rocket Pharmaceuticals Inc Borsa (RCKT) Ultime notizie

Rocket Pharmaceuticals Inc (RCKT)'s stock chart: A technical perspective – US Post News - US Post News

US Post News

Los Angeles Capital Management LLC Purchases 10538 Shares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) - Defense World

Defense World

Q2 2024 Earnings Estimate for Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) Issued By Leerink Partnrs - MarketBeat

MarketBeat

Rocket Pharmaceuticals (RCKT) Presents Positive Data from LV Hematology Portfolio - StreetInsider.com

StreetInsider.com

Rocket Pharmaceuticals Presents Positive Data from LV Hematology Portfolio at the 27th Annual Meeting of the ... - Business Wire

Business Wire

Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) to Post Q2 2024 Earnings of ($0.71) Per Share, William Blair Forecasts - MarketBeat

MarketBeat

Rocket Pharmaceuticals Inc Azioni (RCKT) Dati Finanziari

Rocket Pharmaceuticals Inc (RCKT) Reddito netto 2024

Rocket Pharmaceuticals Inc (RCKT) Flusso di cassa 2024

Rocket Pharmaceuticals Inc (RCKT) Utile per azione 2024

Rocket Pharmaceuticals Inc Azioni (RCKT) insider trading